Dr Christina Kulis

Research Officer

Institute for Molecular Bioscience

+61 7 334 62368

c.kulis@imb.uq.edu.au

Featured projects	Duration
The quest for drug discovery

Publications

Journal Articles (3)

Conference Paper (1)

Thesis (1)

Journal Articles

Yarlagadda, Sai, Kulis, Christina, Noakes, Peter G. and Smythe, Mark L. (2021). Hematopoietic prostaglandin D synthase inhibitor PK007 decreases muscle necrosis in DMD mdx model mice. Life, 11 (9) 994, 994. doi: 10.3390/life11090994

Werder, Rhiannon B., Lynch, Jason P., Simpson, Jennifer C., Zhang, Vivian, Hodge, Nick H., Poh, Matthew, Forbes-Blom, Elizabeth, Kulis, Christina, Smythe, Mark L., Upham, John W., Spann, Kirsten, Everard, Mark L. and Phipps, Simon (2018). PGD2/DP2 receptor activation promotes severe viral bronchiolitis by suppressing IFN-λ production. Science Translational Medicine, 10 (440) eaao0052, eaao0052. doi: 10.1126/scitranslmed.aao0052

Tran, Tran T., Kulis, Christina, Long, Steven M., Bryant, Darryn, Adams, Peter and Smythe, Mark L. (2010). Defining scaffold geometries for interacting with proteins: Geometrical classification of secondary structure linking regions. Journal of Computer-Aided Molecular Design, 24 (11), 917-934. doi: 10.1007/s10822-010-9384-y

Conference Paper

Kulis, C., Bourne, G., Kellie, S. and Smythe, M. (2010). Design, synthesis and evaluation of inhibitors targeting the SHP-1 catalytic domain. EPS 2010: The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010. West Sussex, United Kingdom: John Wiley & Sons. doi: 10.1002/psc.1303

Thesis

Christina Kulis (2011). Substrate-based Design of SHP-1 Inhibitors. PhD Thesis, Institute for Molecular Bioscience, The University of Queensland.